The Cell and Gene Therapy Bioanalytical Testing Services Market was valued at USD 541.5 million in 2024, and is projected to reach USD 828.7 million by 2030, rising at a CAGR of 7.40%. Increasing R&D activities related to cell and gene therapy, growth in investments by public organizations for cell and gene therapy research and high potential of gene and cell therapy in treating rare diseases are the key factors driving the growth of the market. ![Cell and Gene Therapy Bioanalytical Testing Services Market]( "Cell and Gene Therapy Bioanalytical Testing Services Market")
Cell and gene therapies have popularly been adopted in the treatment of cancer, autoimmune diseases, and rare diseases. These therapies have shown a significant improvement in patients' clinical conditions, owing to which a significant number of cell and gene therapy drug candidates are in the pipeline. For instance, according to the American Society of Cell and Gene Therapy, over 2,053 gene therapies and 827 non-genetically modified cell therapies were in the pipeline as of January 2023. High number of cell and gene therapy drug candidates in pipeline is promoting the demand for bioanalytical testing services.
Public and private organizations are actively investing in cell and gene therapy-based research. For instance, in April 2023, the California Institute for Regenerative Medicine invested USD 89.0 million in stem cell and gene therapy research. This funding was planned for the development of therapy in the treatment of persistent corneal epithelial defects. Similar fundings in the future is expected to boost the demand for bioanalytical testing services in the forecasted period.
The COVID-19 pandemic had a negative impact on the market for cell & gene therapy bioanalytical testing services. The majority of the cell and gene therapy-based trials were postponed in the pandemic. However, in the post COVID-19 era, the scenario is changing, and many trials are resumed. This is expected to support market growth in the post-COVID-19 period.
This product will be delivered within 2 business days.
Cell and gene therapies have popularly been adopted in the treatment of cancer, autoimmune diseases, and rare diseases. These therapies have shown a significant improvement in patients' clinical conditions, owing to which a significant number of cell and gene therapy drug candidates are in the pipeline. For instance, according to the American Society of Cell and Gene Therapy, over 2,053 gene therapies and 827 non-genetically modified cell therapies were in the pipeline as of January 2023. High number of cell and gene therapy drug candidates in pipeline is promoting the demand for bioanalytical testing services.
Public and private organizations are actively investing in cell and gene therapy-based research. For instance, in April 2023, the California Institute for Regenerative Medicine invested USD 89.0 million in stem cell and gene therapy research. This funding was planned for the development of therapy in the treatment of persistent corneal epithelial defects. Similar fundings in the future is expected to boost the demand for bioanalytical testing services in the forecasted period.
The COVID-19 pandemic had a negative impact on the market for cell & gene therapy bioanalytical testing services. The majority of the cell and gene therapy-based trials were postponed in the pandemic. However, in the post COVID-19 era, the scenario is changing, and many trials are resumed. This is expected to support market growth in the post-COVID-19 period.
Cell And Gene Therapy Bioanalytical Testing Services Market Report Highlights
- The bioavailability & bioequivalence studies dominated with a market share of 35.44% in 2024 and are also expected to witness the fastest growth over the forecast period.
- The non-clinical segment dominated the market in 2024. The stage of development segment has been further classified based on the product type, which includes gene therapy, gene-modified cell therapy, and cell therapy.
- The cell therapy segment dominated the product segment in 2024. Cell therapy is the transplantation of human cells to repair or replace damaged tissue or cells. The gene-modified cell therapy segment is expected to register the fastest growth during the forecast period.
- The oncology segment dominated the market and accounted for the largest revenue share in 2024. The rare diseases segment is expected to register the fastest CAGR during the forecast period.
- North America dominated the cell and gene therapy bioanalytical testing services market and accounted for the largest revenue share of 41.57% in 2024. Asia-Pacific cell and gene therapy bioanalytical testing services are anticipated to witness the fastest CAGR over the forecast period.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Cell & Gene Therapy Bioanalytical Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Significant Number of Cell & Gene Therapy Drug Candidates Under Clinical Trials
3.2.1.2. High Public and Private Investments Across Research and Development for Novel Cell & Gene Products
3.2.1.3. High Focus of Biopharmaceutical Companies to Reduce Operational Costs Promoting the Demand for Outsourcing
3.2.2. Market Restraint Analysis
3.2.2.1. Availability of Alternative Treatment Options at Lower Cost
3.2.2.2. Quality Issues Associated With Outsourcing
3.3. Clinical Trials Volume Analysis (2024)
3.3.1. Total Number Of Clinical Trials By Region
3.3.2. Total Number Of Clinical Trials, By Phase
3.3.3. Total Number Of Clinical Trials, By Study Design
3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
3.4. Pricing Model Analysis
3.5. Technology Landscape
3.6. Market Analysis Tools
3.6.1. Porter’s Five Force Analysis
3.6.2. PESTEL by SWOT Analysis
3.6.3. COVID-19 Impact Analysis
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Significant Number of Cell & Gene Therapy Drug Candidates Under Clinical Trials
3.2.1.2. High Public and Private Investments Across Research and Development for Novel Cell & Gene Products
3.2.1.3. High Focus of Biopharmaceutical Companies to Reduce Operational Costs Promoting the Demand for Outsourcing
3.2.2. Market Restraint Analysis
3.2.2.1. Availability of Alternative Treatment Options at Lower Cost
3.2.2.2. Quality Issues Associated With Outsourcing
3.3. Clinical Trials Volume Analysis (2024)
3.3.1. Total Number Of Clinical Trials By Region
3.3.2. Total Number Of Clinical Trials, By Phase
3.3.3. Total Number Of Clinical Trials, By Study Design
3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
3.4. Pricing Model Analysis
3.5. Technology Landscape
3.6. Market Analysis Tools
3.6.1. Porter’s Five Force Analysis
3.6.2. PESTEL by SWOT Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis
4.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type: Segment Dashboard
4.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type: Movement Analysis
4.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Test Type, 2018-2030 (USD Million)
4.4. Bioavailability & Bioequivalence Studies
4.4.1. Bioavailability & Bioequivalence Studies Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Pharmacokinetics
4.5.1. Pharmacokinetics Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Pharmacodynamics
4.6.1. Pharmacodynamics Market Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Others
4.7.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type: Movement Analysis
4.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Test Type, 2018-2030 (USD Million)
4.4. Bioavailability & Bioequivalence Studies
4.4.1. Bioavailability & Bioequivalence Studies Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Pharmacokinetics
4.5.1. Pharmacokinetics Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Pharmacodynamics
4.6.1. Pharmacodynamics Market Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Others
4.7.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type Estimates & Trend Analysis
5.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type: Segment Dashboard
5.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type: Movement Analysis
5.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Product Type, 2018-2030 (USD Million)
5.4. Gene Therapy
5.4.1. Gene Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.2. Ex-vivo
5.4.2.1. Ex-vivo Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.3. In-vivo
5.4.3.1. In-vivo Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Gene-Modified Cell Therapy
5.5.1. Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.2. CAR T-cell therapies
5.5.2.1. CAR T-cell therapies Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.3. CAR-NK cell therapy
5.5.3.1. CAR-NK cell therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.4. TCR-T cell therapy
5.5.4.1. TCR-T cell therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.5. Other
5.5.5.1. Other Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Cell Therapy
5.6.1. Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
5.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type: Movement Analysis
5.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Product Type, 2018-2030 (USD Million)
5.4. Gene Therapy
5.4.1. Gene Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.2. Ex-vivo
5.4.2.1. Ex-vivo Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.3. In-vivo
5.4.3.1. In-vivo Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Gene-Modified Cell Therapy
5.5.1. Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.2. CAR T-cell therapies
5.5.2.1. CAR T-cell therapies Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.3. CAR-NK cell therapy
5.5.3.1. CAR-NK cell therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.4. TCR-T cell therapy
5.5.4.1. TCR-T cell therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.5. Other
5.5.5.1. Other Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Cell Therapy
5.6.1. Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type, Estimates & Trend Analysis
6.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Stage of Development by Product Type: Segment Dashboard
6.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Stage of Development by Product Type: Movement Analysis
6.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Stage of Development by Product Type, 2018-2030 (USD Million)
6.4. Non-Clinical
6.4.1. Non-Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.2. Gene Therapy
6.4.2.1. Gene Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.3. Gene-Modified Cell Therapy
6.4.3.1. Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.4. Cell Therapy
6.4.4.1. Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Clinical
6.5.1. Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.2. Gene Therapy
6.5.2.1. Gene Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.3. Gene-Modified Cell Therapy
6.5.3.1. Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.4. Cell Therapy
6.5.4.1. Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Stage of Development by Product Type: Movement Analysis
6.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Stage of Development by Product Type, 2018-2030 (USD Million)
6.4. Non-Clinical
6.4.1. Non-Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.2. Gene Therapy
6.4.2.1. Gene Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.3. Gene-Modified Cell Therapy
6.4.3.1. Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.4.4. Cell Therapy
6.4.4.1. Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Clinical
6.5.1. Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.2. Gene Therapy
6.5.2.1. Gene Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.3. Gene-Modified Cell Therapy
6.5.3.1. Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5.4. Cell Therapy
6.5.4.1. Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Cell & Gene Therapy Bioanalytical Testing Services Market: Indication Estimates & Trend Analysis
7.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication: Segment Dashboard
7.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication: Movement Analysis
7.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Indication, 2018-2030 (USD Million)
7.4. Oncology
7.4.1. Oncology Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Infectious Diseases
7.5.1. Infectious Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Neurological disorders
7.6.1. Neurological disorders Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7. Rare Diseases
7.7.1. Rare Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8. Others
7.8.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
7.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication: Movement Analysis
7.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Indication, 2018-2030 (USD Million)
7.4. Oncology
7.4.1. Oncology Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Infectious Diseases
7.5.1. Infectious Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Neurological disorders
7.6.1. Neurological disorders Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7. Rare Diseases
7.7.1. Rare Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8. Others
7.8.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Cell & Gene Therapy Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2024 & 2030
8.3. North America
8.3.1. North America Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.2. U.S
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. U.S. Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Canada Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.4. Mexico
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Mexico Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4. Europe
8.4.1. Europe Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. UK Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Germany Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.4. France
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. France Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.5. Italy
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Italy Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.6. Spain
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Spain Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.7. Denmark
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Denmark Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Sweden Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Framework
8.4.9.4. Norway Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Asia Pacific
8.5.1. Asia Pacific Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.2. Japan
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Japan Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. China Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. India Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.5. Australia
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Australia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.6. South Korea
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. South Korea Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.7. Thailand
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Thailand Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Latin America
8.6.1. Latin America Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Brazil Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.3. Argentina
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Argentina Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7. MEA
8.7.1. MEA Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.2. South Africa
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. South Africa Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.4. UAE
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. UAE Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Kuwait Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2. Regional Market Share Analysis, 2024 & 2030
8.3. North America
8.3.1. North America Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.2. U.S
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. U.S. Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Canada Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.4. Mexico
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Mexico Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4. Europe
8.4.1. Europe Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. UK Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Germany Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.4. France
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. France Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.5. Italy
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Italy Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.6. Spain
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Spain Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.7. Denmark
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Denmark Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Sweden Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Framework
8.4.9.4. Norway Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Asia Pacific
8.5.1. Asia Pacific Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.2. Japan
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Japan Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. China Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. India Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.5. Australia
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Australia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.6. South Korea
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. South Korea Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.7. Thailand
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Thailand Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Latin America
8.6.1. Latin America Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Brazil Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.3. Argentina
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Argentina Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7. MEA
8.7.1. MEA Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.2. South Africa
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. South Africa Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.4. UAE
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. UAE Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Kuwait Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Company Market Share/Assessment Analysis, 2024
9.3. Company Profiles
9.3.1. BioAgilytix Labs
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. KCAS Bioanalytical Services
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. IQVIA, Inc.
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Laboratory Corporation of America Holdings
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Prolytix
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Pharmaron
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Charles River Laboratories
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Syneos Health
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. SGS SA
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Service Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Intertek Group Plc
9.3.11.1. Company Overview
9.3.11.2. Financial Performance
9.3.11.3. Service Benchmarking
9.3.11.4. Strategic Initiatives
9.2. Company Market Share/Assessment Analysis, 2024
9.3. Company Profiles
9.3.1. BioAgilytix Labs
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. KCAS Bioanalytical Services
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. IQVIA, Inc.
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Laboratory Corporation of America Holdings
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Prolytix
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Pharmaron
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Charles River Laboratories
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Syneos Health
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. SGS SA
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Service Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Intertek Group Plc
9.3.11.1. Company Overview
9.3.11.2. Financial Performance
9.3.11.3. Service Benchmarking
9.3.11.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 4. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 5. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 6. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 7. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Region, 2018-2030 (USD Million)
Table 8. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 9. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 10. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 11. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 12. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 13. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 14. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 15. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 16. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 17. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 18. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 19. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 20. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 21. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 22. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 23. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 24. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 25. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 26. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 27. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 28. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 29. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 30. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 31. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 32. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 33. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 34. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 35. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 36. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 37. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 38. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 39. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 40. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 41. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 42. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 43. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 44. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 45. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 46. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 47. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 48. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 49. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 50. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 51. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 52. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 53. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 54. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 55. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 56. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 57. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 58. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 59. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 60. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 61. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 62. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 63. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 64. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 65. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 66. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 67. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 68. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 69. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 70. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 71. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 72. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 73. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 74. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 75. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 76. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 77. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 78. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 79. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 80. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 81. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 82. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 83. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 84. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 85. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 86. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 87. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 88. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 89. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 90. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 91. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 92. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 93. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 94. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 95. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 96. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 97. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 98. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 99. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 100. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 101. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 102. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 103. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 104. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 105. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 106. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 107. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 108. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 109. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 110. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 111. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 112. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 113. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 114. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 115. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 116. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 117. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 118. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 119. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 120. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 121. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 122. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 123. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 124. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 2. List of Abbreviations
Table 3. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 4. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 5. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 6. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 7. Global Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Region, 2018-2030 (USD Million)
Table 8. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 9. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 10. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 11. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 12. North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 13. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 14. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 15. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 16. U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 17. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 18. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 19. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 20. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 21. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 22. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 23. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 24. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 25. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 26. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 27. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 28. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 29. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 30. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 31. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 32. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 33. UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 34. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 35. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 36. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 37. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 38. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 39. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 40. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 41. France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 42. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 43. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 44. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 45. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 46. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 47. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 48. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 49. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 50. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 51. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 52. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 53. Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 54. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 55. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 56. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 57. Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 58. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 59. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 60. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 61. Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 62. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 63. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 64. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 65. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 66. Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 67. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 68. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 69. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 70. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 71. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 72. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 73. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 74. China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 75. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 76. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 77. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 78. India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 79. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 80. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 81. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 82. Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 83. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 84. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 85. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 86. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 87. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 88. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 89. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 90. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 91. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 92. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 93. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 94. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 95. Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 96. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 97. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 98. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 99. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 100. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 101. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 102. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 103. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 104. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Country, 2018-2030 (USD Million)
Table 105. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 106. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 107. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 108. Middle East & Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 109. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 110. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 111. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 112. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 113. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 114. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 115. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 116. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 117. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 118. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 119. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 120. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
Table 121. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Test Type, 2018-2030 (USD Million)
Table 122. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Product Type, 2018-2030 (USD Million)
Table 123. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Stage of Development by Product Type, 2018-2030 (USD Million)
Table 124. Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, by Indication, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 Cell & Gene Therapy Bioanalytical Testing Services Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type outlook and key takeaways
Figure 20 Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type movement analysis
Figure 21 Bioavailability & Bioequivalence Studies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 Pharmacokinetics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Pharmacodynamics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 24 Other Test Type Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 25 Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type outlook and key takeaways
Figure 26 Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type movement analysis
Figure 27 Gene Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 Ex-vivo Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 29 In-vivo Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 30 Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 31 CAR T-cell therapies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 CAR-NK cell therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 TCR-T cell therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Other Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type outlook and key takeaways
Figure 37 Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type movement analysis
Figure 38 Non-Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Gene Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 Gene Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Cell & Gene Therapy Bioanalytical Testing Services Market: Indication outlook and key takeaways
Figure 47 Cell & Gene Therapy Bioanalytical Testing Services Market: Indication movement analysis
Figure 48 Oncology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 Infectious Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Neurological disorders Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 51 Rare Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 Regional Marketplace: Key Takeaways
Figure 54 North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Key country dynamics
Figure 56 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Key country dynamics
Figure 58 Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Key country dynamics
Figure 60 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 61 Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 62 Key country dynamics
Figure 63 UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 Key country dynamics
Figure 65 Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 66 Key country dynamics
Figure 67 France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 68 Key country dynamics
Figure 69 Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 70 Key country dynamics
Figure 71 Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 72 Key country dynamics
Figure 73 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 74 Key country dynamics
Figure 75 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 76 Key country dynamics
Figure 77 Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 78 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 79 Key country dynamics
Figure 80 Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 81 Key country dynamics
Figure 82 China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 83 Key country dynamics
Figure 84 India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 85 Key country dynamics
Figure 86 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 87 Key country dynamics
Figure 88 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 89 Key country dynamics
Figure 90 Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 91 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 92 Key country dynamics
Figure 93 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 94 Key country dynamics
Figure 95 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 96 MEA Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 97 Key country dynamics
Figure 98 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 99 Key country dynamics
Figure 100 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 101 Key country dynamics
Figure 102 UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 103 Key country dynamics
Figure 104 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 105 Key company categorization
Figure 106 Service heat map analysis
Figure 107 Strategic framework
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 Cell & Gene Therapy Bioanalytical Testing Services Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type outlook and key takeaways
Figure 20 Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type movement analysis
Figure 21 Bioavailability & Bioequivalence Studies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 Pharmacokinetics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Pharmacodynamics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 24 Other Test Type Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 25 Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type outlook and key takeaways
Figure 26 Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type movement analysis
Figure 27 Gene Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 Ex-vivo Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 29 In-vivo Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 30 Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 31 CAR T-cell therapies Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 CAR-NK cell therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 TCR-T cell therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Other Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type outlook and key takeaways
Figure 37 Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type movement analysis
Figure 38 Non-Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Gene Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Clinical Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 Gene Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Gene-Modified Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 Cell Therapy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Cell & Gene Therapy Bioanalytical Testing Services Market: Indication outlook and key takeaways
Figure 47 Cell & Gene Therapy Bioanalytical Testing Services Market: Indication movement analysis
Figure 48 Oncology Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 Infectious Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Neurological disorders Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 51 Rare Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 Regional Marketplace: Key Takeaways
Figure 54 North America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Key country dynamics
Figure 56 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Key country dynamics
Figure 58 Canada Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Key country dynamics
Figure 60 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 61 Europe Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 62 Key country dynamics
Figure 63 UK Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 Key country dynamics
Figure 65 Germany Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 66 Key country dynamics
Figure 67 France Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 68 Key country dynamics
Figure 69 Italy Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 70 Key country dynamics
Figure 71 Spain Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 72 Key country dynamics
Figure 73 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 74 Key country dynamics
Figure 75 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 76 Key country dynamics
Figure 77 Norway Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 78 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 79 Key country dynamics
Figure 80 Japan Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 81 Key country dynamics
Figure 82 China Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 83 Key country dynamics
Figure 84 India Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 85 Key country dynamics
Figure 86 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 87 Key country dynamics
Figure 88 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 89 Key country dynamics
Figure 90 Australia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 91 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 92 Key country dynamics
Figure 93 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 94 Key country dynamics
Figure 95 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 96 MEA Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 97 Key country dynamics
Figure 98 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 99 Key country dynamics
Figure 100 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 101 Key country dynamics
Figure 102 UAE Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 103 Key country dynamics
Figure 104 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 105 Key company categorization
Figure 106 Service heat map analysis
Figure 107 Strategic framework
Companies Mentioned
The major companies featured in this Cell and Gene Therapy Bioanalytical Testing Services market report include:- BioAgilytix Labs
- KCAS Bioanalytical Services
- IQVIA, Inc.
- Laboratory Corporation of America Holdings
- Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
- Prolytix
- Pharmaron
- Charles River Laboratories
- Syneos Health
- SGS SA
- Intertek Group Plc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 261 |
| Published | May 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 541.5 Million |
| Forecasted Market Value ( USD | $ 828.7 Million |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
